Sarah Tasian

49PUBLICATIONS
365CO-AUTHORS
Haematological tumoursAdolescent healthInformation extraction and fusionInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 24, 2026
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.

|May 08, 2026
Gilteritinib and chemotherapy in children with relapsed/refractory FLT3-ITD AML: results from the phase 1/2 SKIPPER trial.

|Apr 17, 2026
The Common Fund Data Ecosystem (CFDE).

|Mar 23, 2026
From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents.

Sarah K Tasian, Judith M Boer, Monique L den Boer

|Dec 06, 2025
Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia.

Ke Wang, Shayan Saniei, Nikita Poddar

|Oct 17, 2025
Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel.

C Michel Zwaan, Sarah K Tasian, Richard Aplenc

Pageof 9

Frequent Collaborators

5 joint publications

Mignon L Loh

4 joint publications

Katharina E Hayer

4 joint publications

Andrei Thomas-Tikhonenko

4 joint publications

Yoseph Barash